Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (16459)	11/20/2003 11:35:01 PM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

Cacaito, you have NO idea what the PASI score was on the others..........THEY DIDN'T remain in the trial. BUT you do know that>>>>>..."Among the 194 patients who remained in the trial through week 84, 67 percent (130/194) of patients achieved a PASI 75 response"...<<<<<<<< Who knows what this will translate into in the real world across the country now that Raptiva has been shipped. Now, where is Amevive's 84 week trial results????LOL Oh I forgot you CAN'T use Amevive for longer than 12 weeks at a time!!!!!! Raptiva, THE ONLY APPROVED biologic for CONTINUOUS use! AND no WEEKLY T cell counts!!!!! Why even TRY to compare Amevive with Raptiva????? BTW, I didn't see Amevive even in the running in the NEW ENGLAND JOURNAL of MEDICINE article. Why not????LOL BTW, BTW, MOST people would rather take a beating than an IM injection much less one IM injection at the physician's office ONCE A WEEK for TWELVE WEEKS!!!!! Also you have the honor of being stuck each week for T cell counts!!!! Then after the twelve weeks it is a crapshoot on what results you get AND you are STUCK with those results because you can't have anymore Amevive for 12 weeks. WOW!!!!! Cacaito, the 75 reps from DNA are going to have a field day with all of this.